Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid LeukemiaCourtney D. DiNardo, Hagop M. Kantarjian, Naval Daver et al.|Journal of Clinical Oncology|2021Cited by 333
Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapyWei Wang, Shimin Hu, Jörge E. Cortes et al.|Blood|2016Cited by 191
P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphomaXuan J. Wang, Shaoying Li, L. Jeffrey Medeiros et al.|Modern Pathology|2016Cited by 92